Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern
- PMID: 15360096
- PMCID: PMC7147208
- DOI: 10.1016/j.amjmed.2004.07.007
Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern
Abstract
Community-acquired pneumonia (CAP) is the sixth most common cause of death in the United States and the leading cause of death from infectious diseases. It is associated with significant morbidity and mortality, and poses a major economic burden to the healthcare system. Streptococcus pneumoniae is the leading cause of CAP. Other common bacterial causes include Haemophilus influenzae as well as atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species). Increasing resistance to a variety of antimicrobial agents has been documented in S. pneumoniae and is common in H. influenzae as well. Successful empiric therapy is paramount to the management of CAP to avoid treatment failure and subsequent associated costs. Given that resistance is increasing among respiratory pathogens, and S. pneumoniae is the most common etiologic agent identified in CAP, strategies for antimicrobial therapy should be based on the likely causative pathogen, the presence of risk factors for infection with resistant bacteria, and local resistance patterns.
Figures




Similar articles
-
Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.J Infect Chemother. 2007 Oct;13(5):296-301. doi: 10.1007/s10156-007-0539-2. Epub 2007 Oct 30. J Infect Chemother. 2007. PMID: 17982717 Clinical Trial.
-
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.Diagn Microbiol Infect Dis. 2007 May;58(1):1-7. doi: 10.1016/j.diagmicrobio.2007.01.019. Epub 2007 Apr 3. Diagn Microbiol Infect Dis. 2007. PMID: 17408904
-
Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):863-70. doi: 10.1007/BF01700551. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9495665
-
Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.Int J Antimicrob Agents. 2010 Sep;36(3):197-204. doi: 10.1016/j.ijantimicag.2010.04.013. Epub 2010 Jun 16. Int J Antimicrob Agents. 2010. PMID: 20558045 Review.
-
Burden of community-acquired pneumonia in North American adults.Postgrad Med. 2010 Mar;122(2):130-41. doi: 10.3810/pgm.2010.03.2130. Postgrad Med. 2010. PMID: 20203464 Review.
Cited by
-
Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005-2016.Yonsei Med J. 2020 Mar;61(3):243-250. doi: 10.3349/ymj.2020.61.3.243. Yonsei Med J. 2020. PMID: 32102125 Free PMC article.
-
TLR4 mediates pneumolysin-induced ATF3 expression through the JNK/p38 pathway in Streptococcus pneumoniae-infected RAW 264.7 cells.Mol Cells. 2015 Jan 31;38(1):58-64. doi: 10.14348/molcells.2015.2231. Epub 2014 Dec 16. Mol Cells. 2015. PMID: 25518930 Free PMC article.
-
Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia in Indian Adolescents and Adults: A Systematic Review and Meta-Analysis.Clin Med Insights Circ Respir Pulm Med. 2019 Jul 31;13:1179548419862790. doi: 10.1177/1179548419862790. eCollection 2019. Clin Med Insights Circ Respir Pulm Med. 2019. PMID: 31391784 Free PMC article.
-
Cost-utility analysis of the universal pneumococcal vaccination programme for older adults in Norway.Hum Vaccin Immunother. 2022 Nov 30;18(6):2101333. doi: 10.1080/21645515.2022.2101333. Epub 2022 Aug 2. Hum Vaccin Immunother. 2022. PMID: 35917277 Free PMC article.
-
Chronic pulmonary LPS tolerance induces selective immunosuppression while maintaining the neutrophilic response.Shock. 2010 Feb;33(2):162-9. doi: 10.1097/SHK.0b013e3181aa9690. Shock. 2010. PMID: 19487981 Free PMC article.
References
-
- Murphy SL. Deaths: Final Data for 1998. Hyattsville, MD: US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2000. National Vital Statistics Reports, Volume 48, No. 11. DHHS publication no. PHS 2000-1120 - PubMed
-
- Centers for Disease Control and Prevention Premature deaths, monthly mortality, and monthly physician contacts: United States. MMWR Morb Mortal Wkly Rep. 1997;46:556–561. - PubMed
-
- Marston B.J, Plouffe J.F, File T.M, Jr, Community-Based Pneumonia Incidence Study Group Incidence of community-acquired pneumonia requiring hospitalization. Arch Intern Med. 1997;157:1709–1718. - PubMed
-
- Fine M.J, Auble T.E, Yealy D.M. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous